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Introduction
Traffic injuries represent a major public health issue and alcohol is a well-recognised risk 
factor for motor vehicle crashes (MVC).1 Driving under the influence of drugs (DUID) other 
than alcohol is now considered to be an increasing cause of traffic accidents worldwide.2 
Exposure to illicit drugs impairs driving ability owing to their effects on the central nervous 
system, psychomotor performance, and risk-taking behaviour. Studies have shown the 
association between the use of psychoactive substances other than alcohol and increased 
accident risk.3-5
 A roadside survey in Thailand showed a prevalence of psychoactive drug use among 
general drivers not involved in MVC to be 9.7%.6 Alcohol or psychoactive drugs were found 
in 4.5% of drivers in a random sampling survey in Norway.7 A high proportion of injured 
drivers have been reported to test positive in overseas studies involving psychoactive 
drug screening. Siliquini et al8 revealed positive psychoactive substances present in 18.5% 
of the drivers involved in road traffic crashes in Italy. In a Swedish study, 13% of non–
fatally injured drivers tested positive for pharmaceuticals which could impair driving.9 A 
study conducted in Belgium involving 211 injured drivers showed that 12.3% screened 
positive for drugs, and about half of them tested positive for alcohol as well.10 Among 
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	 目的	 探討因非致命交通事故被送往香港一所創傷中心的濫
藥司機的比率及特徵。
	 設計	 橫斷面研究。
	 安排	 香港一所專責指定創傷中心／分區急症室。
	 參與者	 2007年1月1日至12月31日期間，被送往創傷中心的
非致命交通事故的傷者。
	主要結果測量	 用商業用床邊尿液免疫試劑檢測病人是否曾濫藥。
	 結果	 395位接受藥物測試的受傷司機中，10%呈陽性反
應。氯胺酮是最經常被檢測到的藥物，佔測試者中
45%。25歲以下年輕司機對藥物測試呈陽性反應有
明顯較高比率（比數比=2.3；95%置信區間，1.0-5.2
；P=0.04），佔21%。本研究發現，對藥物測試呈陽
性反應的個案，與發生車禍的時間有關，即午夜到清
晨時分發生的車禍有較高比率（比數比=2.2；95%置
信區間，0.9-5.3；P=0.07），可是與司機性別、駕駛
車輛的款式、或於車禍發生的日子並無顯著關係。
	 結論	 本研究中非致命交通事故受傷司機濫藥比率為10%。
對藥物測試呈陽性反應的個案中，25歲以下的年輕司
機有明顯較高的比率。這些結果顯示有需要修改法例
以及對懷疑濫藥的司機實施即場藥物測試。
因非致命交通事故被送往香港一所創傷中心
的濫藥司機的比率
injured drivers, there was a much higher prevalence 
of persons screened drug-positive reported from the 
United States, ranging from 22.6 to 50.9%.11-14 In a local 
epidemiological study, 56% of the deceased drivers 
from single-vehicle crashes had alcohol and/or drugs 
in their bodies; 7% were positive for drugs only and 
5% were for both drugs and alcohol.15 However, there 
are no local data on the prevalence of abusive drug 
use in drivers of non-fatal motor vehicle casualties. 
 This study therefore aimed to evaluate the 
prevalence and characteristics of abusive drug 
exposure among the non-fatal motor vehicle driver 
casualties presenting to a designated trauma centre 
in Hong Kong.
Methods
This study was conducted in a regional accident and 
emergency department, which was also one of the 
five designated trauma centres in Hong Kong. 
 The study period extended from 1 January 
2007 to 31 December 2007. All motor vehicle driver 
casualties who presented to the trauma centre for 
treatment of injuries after a crash were approached 
for assessment. Fatal cases (certified dead in the 
emergency room) were excluded from the sample. 
All other injured drivers were considered eligible 
for recruitment, whatever their outcome after 
admission. The urine tests were performed if verbal 
consent was obtained from the patient or if deemed 
strongly indicated by the in-charge doctor (to assist 
management when consciousness was impaired). 
All eligible injured drivers who were screened had 
urine testing for abusive drug exposure, if there were 
clinical indications for drug screening or if verbal 
consent could be obtained. Consenting drivers were 
reassured that all information obtained would be 
kept confidential and used for scientific and not legal 
purposes. 
 We used two sets of bedside urine immunoassay 
kits (ACON Laboratories; San Diego, US) for 
screening. One was a multiple panel kit for 10 different 
drugs (amphetamine, methamphetamine, cocaine, 
3,4-methylenedioxymethamphetamine [MDMA], 
tetrahydrocannabinol [THC], morphine, methadone, 
benzodiazepines, tricyclic antidepressants [TCAs], 
and barbiturates), and one was a single panel kit for 
ketamine. As TCAs and barbiturates are sometimes 
prescribed as therapeutic medications, these agents 
were not considered to be abusive drugs and were not 
included in the study. Epidemiological characteristics 
of the drivers were also collected. 
 The point prevalence of positive urine drug 
screening in these motor vehicle driver casualties 
was determined. Descriptive statistics were 
employed to illustrate the frequency of the positive 
results for different abused drugs. Binary logistic 
regression analysis was used to find any association 
between positive urine screening and characteristics 
of the drivers (gender, age [<25 or ≥25 years], class 
of motor vehicle), time of the MVC event (midnight-
dawn [00:00-07:59], daytime [08:00-15:59], or evening 
[16:00-23:59]), and whether on a weekday (Monday to 
Friday) or a weekend (Saturday and Sunday).
 The significance level was set at 5%. The 
goodness-of-fit of the regression model was examined 
by the log likelihood statistic. STATA (StataCorp, 
College Station, US) was employed for the statistical 
analysis. The study was approved by the cluster ethics 
committee of the Hospital Authority of Hong Kong 
and the Human Research Ethics Committee for Non-
clinical Faculties of the University of Hong Kong.
Results
A total of 783 casualty drivers presented to our 
trauma centre during the study period, of whom 
395 (50%) had urine drug screening. Among the 
latter, 150 drove private cars, 80 drove motorcycles, 
and 165 drove other vehicles. The mean and median 
ages of the sampled drivers were 37 and 28 (range, 
18-63) years, respectively. The main reasons for not 
participating in the screening were withholding 
consent and failure to initiate the consent process 
prior to discharge.
 Of 395 drivers, 38 (10%) of the screened drivers 
tested positive for at least one illicit drug. Ketamine 
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was the most frequently detected abusive substance 
(n=17; 45%) in the sample (Fig); 26 (68%) tested 
positive for a single drug and 12 (32%) for more than 
one drug. Among the latter 12 drivers, seven tested 
positive for three or more drugs. The multiple drug 
combinations in the urine of these 12 drivers are 
shown in Table 1.
 Table 2 shows demographic and other features 
of relevance to the sample of screened drivers. There 
were 63 (16%) drivers who were younger than 25 
years, and 360 (91%) were male. Approximately 71% 
(281/395) of these casualties occurred on weekdays 
(Monday to Friday); 20% of the sampled drivers 
presented to the emergency department during the 
period 00:00-07:59 hours.
 Table 2 also shows the results of binary logistic 
regression, which indicates a significantly higher 
frequency of urine testing positive for drugs among 
drivers aged below 25 years (odds ratio=2.3; 95% 
confidence interval, 1.0-5.2; P=0.04). Motor vehicle 
crashes occurring in the period midnight to dawn 
(00:00-07:59) were associated with a higher frequency 
of positive drug screening (odds ratio=2.2; 95% 
confidence interval, 0.9-5.3; P=0.07). There was no 
significant association with respect to vehicle types, 
genders, day of the accident (weekdays vs weekend) 
and urine testing positive. The model generally 
demonstrated a good fit with the observations.
Discussion
Drug abuse is an important social problem in Hong 
Kong. Apart from heroin, psychoactive substances 
such as ketamine, methamphetamine, and cannabis 
are commonly abused.16 Driving under the influence 
of drugs has recently gained considerable attention 
as a potential threat to local road traffic safety. In 
reply to Legislative Council questions on 24 February 
2010, the Secretary for Transport and Housing stated 
that there were four traffic accidents involving 
drivers suspected of DUID in the past 12 months. 
This may be an underestimate however, due to the 
limited investigation powers of the police that relate 
to current legislation about such driving.
 Abusive drugs are mostly psychoactive 
substances. Theoretically, they have detrimental 
effects on psychomotor performance and may impair 
driving skills. The association between psychoactive 
substance use and driving impairment had been 
investigated in various types of studies, involving 
laboratories, simulators, as well as on-road and field 
investigations. 
 Ecstasy, also known as MDMA, and 
methamphetamine (ice) are commonly abused 
drugs in Hong Kong. Exposure to these stimulants 
could cause divided attention deficits in performing 
tasks and decreased appreciation of risks during 
driving.17 However, laboratory studies have yielded 
inconsistent results with respect to impaired 
driving performance.18 Low blood concentrations 
of amphetamine, methamphetamine, and ecstasy 
have been found in persons arrested for DUID.19 
The increased risk of MVC may actually be related 
to fatigue and sleep deprivation. In contrast to such 
stimulants, the relationship between the risk of MVC 
and benzodiazepine use has been well proven.20 
Apart from alcohol, cannabis is the most frequently 
detected abused substance in drivers involved in MVC 
reported in the literature.18 Compared with ketamine, 
cannabis abuse in Hong Kong is less common and 
there is actually a decreasing trend.16 Experimental 
studies show that THC, the major psychoactive 
compound in cannabis, acutely impairs cognition, 
psychomotor function, and driving performance in a 
dose-related manner. According to epidemiological 
analyses, combined use of alcohol and cannabis 
significantly increases the risk of a MVC.21
 In Hong Kong, heroin is one of the most 
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FIG. Distribution of abusive drugs detected in the screening test of injured drivers
Category/drug involved Frequency
Two positive results 
Marijuana + methamphetamine 1
Ketamine + cocaine 2
Ketamine + morphine 2
Three or more positive results
Ketamine + methamphetamine + morphine 3
Ketamine + amphetamine + methamphetamine 1
Ketamine + benzodiazepines + cocaine + marijuana 1
Barbiturate + benzodiazepines + morphine 1
Benzodiazepines + morphine + methadone 1
TABLE 1. Drug combinations detected in patients with urine that tested positive
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commonly abused substances.16 However, the 
association of opioid intoxication and consequential 
sedative effects with the risk of MVC has not been 
well studied.18 In Hong Kong, there has been a sharply 
rising trend in ketamine abuse in recent years,16 but 
no local study has explored its impact on road traffic 
safety. Ketamine use is associated with poor body 
coordination and balance,22 which could impair 
driving performance. 
 When purchasing standard comprehensive 
private vehicle insurance policy in Hong Kong, being 
‘a young driver’ results in an excess charge. A young 
driver is usually defined as aged less than 25 years. 
According to the data for the year 2003 to 2007 from 
the local Transport Department, 8 to 10% of motor 
vehicle drivers involved in crashes were under 25 
years.23 Notably, motor vehicle driver casualties in 
persons aged under 25 years accounted for 34% 
(13/38) of our sample who tested drug positive, which 
is substantially higher than that anticipated from the 
proportion of young subjects in our cohort of drivers 
who crashed. This observation is consistent with our 
finding that being a driver aged under 25 years was 
an independent factor associated with positive drug 
screening (odds ratio=2.3). Positive drug screening 
should not be interpreted as equivalent to drug 
intoxication. On the other hand, a drug abuse habit 
may be associated with other forms of high-risk driving 
behaviour, including drink driving, an increased risk 
of crashing, and having an adverse crash outcome. 
Therefore, the exact association between abused 
drug intoxications and crash outcomes cannot be 
established directly from the present study that used 
drug screening as the main measure of outcome.
 According to the voluntary reporting system 
of the Central Registry of Drug Abuse, heroin and 
ketamine are the most commonly reported abused 
drugs. Ketamine is the most popular psychoactive 
substance abused by the persons aged less than 21 
years.16 Our study revealed that ketamine was the 
most frequently detected drug among drivers who 
screened positive. Among those testing positive 
for more than one drug, ketamine was also the 
commonest drug used in the combination (Table 
1). In general, drugs detected in impaired drivers 
could reflect the general pattern of drug use in 
the community,18 and our results indicate a high 
frequency of ketamine use in Hong Kong. 
 This study showed that driver casualties 
presenting to our trauma centre during the dawn 
to morning period were more likely to have urine 
specimens that screened positive than those 
presenting during the daytime. This result may be 
explained by the wider range of entertainment 
activities (dancing and clubbing) taking place at 
night. However, there was no significant difference in 
the association with respect to testing drug-positive 
No. (%) of drivers (n=395) No. (%) of test positive Odds ratio (95% 
confidence interval)
P value
Time
00:00-07:59 79 (20) 14 (18) 2.2 (0.9-5.3) 0.07‡
08:00-15:59 156 (39) 12 (8) 1
16:00-23:59 160 (41) 12 (8) 0.9 (0.4-2.2) 0.89
Age (years)
<25 63 (16) 13 (21) 2.3 (1.0-5.2) 0.04†
≥25 332 (84) 25 (8) 1
Vehicle
Motorcycle 80 (20) 7 (9) 1.2 (0.4-4.2) 0.74
Private car 150 (38) 21 (14) 1.9 (0.6-5.5) 0.26
Taxi 82 (21) 5 (6) 1.0 (0.3-3.7) 0.98
Others 83 (21) 5 (6) 1
Gender
Male 360 (91) 34 (9) 0.8 (0.3-2.5) 0.69
Female 35 (9) 4 (11) 1
Day
Weekend 114 (29) 10 (9) 0.9 (0.4-1.9) 0.73
Weekday 281 (71) 28 (10) 1
TABLE 2. Characteristics of sampled drivers and results of binary logistic regression for the prevalence of drugged drivers*
* Log likelihood ratio statistics=13.62
† Statistically significant at the 5% level
‡ Statistically significant at the 10% level 
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and weekdays as opposed to weekends. 
 An earlier Hong Kong study showed that 
among all classes of vehicle drivers involved in local 
road traffic accidents in 2007, motorcyclists had the 
highest driver fatality rate (4.4 per 1000 drivers).23 
Our study did not demonstrate a significantly higher 
proportion of urine screened drug-positive among 
motorcyclists, but our results could be limited by the 
small number of motorcyclists in our sample.
 In most of western countries, DUID is covered 
by specific legislation; different countries having 
passed different types of related statutes. These 
statutes require that either the drugs achieve a level 
that renders the driver incapable of driving safely, 
or adopt a zero tolerance whereby drugged drivers 
are prosecuted if defined drugs or metabolites are 
detected in their bodies.24 In Hong Kong, the definition 
of drug driving is not clear. What the legislation states 
is that “a person who drives or attempts to drive or 
is in charge of a motor vehicle on any road while he 
is under the influence of drink or drugs to such an 
extent as to be incapable of having proper control of 
the motor vehicle commits an offence”.25 In contrast 
to drink driving, police officers are not empowered 
to conduct random checks or obtain blood or urine 
samples from DUID suspects for the purpose of 
prosecution under the existing law. Amendment 
of the existing legislations to implement on-site 
compulsory testing of suspected drugged drivers 
may be an important combating strategy. Compulsory 
testing should be considered in drivers involved 
in any MVC and particularly persons who pass the 
breath alcohol test but fail field sobriety testing. For 
the implementation of random checks, the issue 
may be more complicated and a careful balance 
between the public acceptance and the benefits of 
deterring DUID should be considered. Concerning 
the feasibility of obtaining body fluid samples at 
the scene, saliva could be the preferred matrix for 
roadside drug screening. At present, however, there 
is no commercially available roadside saliva testing 
device for ketamine that has satisfactory sensitivity 
and specificity.
Limitations
Accuracy of immunoassay tests
The cross-reactivity of tested substances with 
other structurally similar compounds often cause 
false positives when based on immunoassays.26-30 
In legal settings requiring proof that a particular 
drug is present beyond doubt, confirmation by gas 
chromatography/mass spectrometry is preferable. 
However due to the limitation of resources and the 
design of our study, all urine testing positive by us 
were considered true positives. Notwithstanding this 
limitation, results from overseas studies involving 
toxicology screening in trauma patients revealed a 
high correlation between drug screening results and 
subsequent laboratory confirmation.31,32
Supportive evidence of driving under the  
influence of drugs by the positive drug screening 
results 
It is often difficult to establish the causal relationship 
between a positive screening result and the MVC. 
Positive screening merely indicates recent exposure 
to the abused drug(s). Some drug screening tests 
detect inactive metabolites of the abused drugs, for 
example, those of cocaine, which persist in the body 
for much longer time than the active compound(s). 
Thus, urine tests provide no proof that the driver was 
under the influence of a drug (ie was intoxicated) and 
that this caused the event. 
Selection bias and response rate of the sample
Santamariña-Rubio et al33 reported that gender, 
attendance time, and waiting time could be 
independent factors for non-participation in drug 
screening tests. We did not assess our sample for any 
such selection biases. Due to voluntary participation, 
the response rate for urine screening was expected 
to be low. Persons who had been exposed to abused 
drugs were considered more likely to refuse the 
tests. Our participation rate was slightly above 50%. 
Thus, 10% may represent a minimal estimate of the 
local prevalence of abused drug exposure in motor 
vehicle driver casualties. 
Conclusions
Driving under the influence of drugs is a recognised 
potential threat to road safety in Hong Kong. Our 
result indicating a 10% prevalence for abused drug 
exposure in local non-fatal motor vehicle drivers 
probably represents a fair-to-conservative estimate. 
The estimated prevalence among drivers aged less 
than 25 years (21%) was significantly higher. These 
results indicate an urgent need to explore objective 
means of identifying DUID and update existing laws 
for the prosecution of this offence.
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